Genital Candida species detected in samples from women in Melbourne, Australia, before and after treatment with antibiotics
- PMID:16954250
- PMCID: PMC1594690
- DOI: 10.1128/JCM.00218-06
Genital Candida species detected in samples from women in Melbourne, Australia, before and after treatment with antibiotics
Abstract
Vulvovaginal candidiasis (VVC) remains a common cause of morbidity, with three-quarters of women affected during their lifetimes. Use of antibiotics is an acknowledged trigger for VVC, which adversely affects women's physical and emotional health. Knowledge of patterns of genital Candida species-level identification is important for management, as Candida species other than Candida albicans often fail first-line treatment. A community sample of women with no vaginal symptoms, and who were prescribed antibiotics, was recruited into this study, where the incidence of genital colonization by various Candida species was documented, as well as symptoms of VVC plus relevant associations, before and after treatment with antibiotics. Self-collected low vaginal swabs were taken prior to and 8 days after completion of antibiotic treatment, and data on various potential risk factors for VVC were collected simultaneously, with complete data being available for 233 participants. Baseline Candida species colonization was present in 21% of women (95% confidence intervals [CI], 17% to 27%), rising to 37% (95% CI, 31% to 44%) after antibiotic treatment. The primary species detected for either period was C. albicans (73%), with Candida glabrata detected in around 20%. Self-assessed proneness to VVC after antibiotic treatment and baseline colonization with Candida spp. were significantly associated with symptomatic VVC after antibiotic treatment. For microbiologically proven candidiasis, VVC symptoms had a sensitivity of 57% and a specificity of 91%. When physicians prescribe antibiotics, the history of risk of VVC is one issue that physicians should discuss with women, particularly those who are self-identified as being prone to VVC. Furthermore, we recommend that definitive microbiological diagnoses be made for women with recurrent symptoms or those failing initial treatment, to guide appropriate therapy.
Figures
Similar articles
- Detection of Candida species by PCR in self-collected vaginal swabs of women after taking antibiotics.Tabrizi SN, Pirotta MV, Rudland E, Garland SM.Tabrizi SN, et al.Mycoses. 2006 Nov;49(6):523-4. doi: 10.1111/j.1439-0507.2006.01312.x.Mycoses. 2006.PMID:17022774
- Effect of antibiotics on vulvovaginal candidiasis: a MetroNet study.Xu J, Schwartz K, Bartoces M, Monsur J, Severson RK, Sobel JD.Xu J, et al.J Am Board Fam Med. 2008 Jul-Aug;21(4):261-8. doi: 10.3122/jabfm.2008.04.070169.J Am Board Fam Med. 2008.PMID:18612052
- Evaluation of risk factors in patients with vulvovaginal candidiasis and the value of chromID Candida agar versus CHROMagar Candida for recovery and presumptive identification of vaginal yeast species.Guzel AB, Ilkit M, Akar T, Burgut R, Demir SC.Guzel AB, et al.Med Mycol. 2011 Jan;49(1):16-25. doi: 10.3109/13693786.2010.497972. Epub 2010 Jul 7.Med Mycol. 2011.PMID:20608776
- Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors.Gonçalves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S.Gonçalves B, et al.Crit Rev Microbiol. 2016 Nov;42(6):905-27. doi: 10.3109/1040841X.2015.1091805. Epub 2015 Dec 21.Crit Rev Microbiol. 2016.PMID:26690853Review.
- [Genital candidiasis].Ono F, Yasumoto S.Ono F, et al.Nihon Rinsho. 2009 Jan;67(1):157-61.Nihon Rinsho. 2009.PMID:19177766Review.Japanese.
Cited by
- Chitosan-Based Nanomedicine to Fight Genital Candida Infections: Chitosomes.Andersen T, Mishchenko E, Flaten GE, Sollid JU, Mattsson S, Tho I, Škalko-Basnet N.Andersen T, et al.Mar Drugs. 2017 Mar 4;15(3):64. doi: 10.3390/md15030064.Mar Drugs. 2017.PMID:28273850Free PMC article.
- Vulvovaginal Candidosis (Excluding Mucocutaneous Candidosis): Guideline of the German (DGGG), Austrian (OEGGG) and Swiss (SGGG) Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry Number 015/072, September 2020).Farr A, Effendy I, Tirri BF, Hof H, Mayser P, Petricevic L, Ruhnke M, Schaller M, Schäfer APA, Willinger B, Mendling W.Farr A, et al.Geburtshilfe Frauenheilkd. 2021 Apr;81(4):398-421. doi: 10.1055/a-1345-8793. Epub 2021 Apr 14.Geburtshilfe Frauenheilkd. 2021.PMID:33867561Free PMC article.
- Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k).Farr A, Effendy I, Frey Tirri B, Hof H, Mayser P, Petricevic L, Ruhnke M, Schaller M, Schaefer APA, Sustr V, Willinger B, Mendling W.Farr A, et al.Mycoses. 2021 Jun;64(6):583-602. doi: 10.1111/myc.13248. Epub 2021 Feb 27.Mycoses. 2021.PMID:33529414Free PMC article.Review.
- Vulvovaginal Candidosis: Current Concepts, Challenges and Perspectives.Sustr V, Foessleitner P, Kiss H, Farr A.Sustr V, et al.J Fungi (Basel). 2020 Nov 7;6(4):267. doi: 10.3390/jof6040267.J Fungi (Basel). 2020.PMID:33171784Free PMC article.Review.
- An Update on the Roles of Non-albicansCandida Species in Vulvovaginitis.Makanjuola O, Bongomin F, Fayemiwo SA.Makanjuola O, et al.J Fungi (Basel). 2018 Oct 31;4(4):121. doi: 10.3390/jof4040121.J Fungi (Basel). 2018.PMID:30384449Free PMC article.Review.
References
- Al-Hedaithy, S. 2002. Spectrum and proteinase production of yeasts causing vaginitis in Saudi Arabian women. Med. Sci. Monit. 8:498-501. - PubMed
- Bauters, T. G., M. A. Dhont, M. I. Temmerman, and H. J. Nelis. 2002. Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women. Am. J. Obstet. Gynecol. 187:569-574. - PubMed
- Beigi, R., L. Meyn, D. Moore, M. Krohn, and S. Hillier. 2004. Vaginal yeast colonization in non-pregnant women: a longitudinal study. Obstet. Gynecol. 104:926-930. - PubMed
- Bernal, S., E. Mazuelos, M. Garcia, A. Aller, M. Martinez, and M. Gutierrez. 1996. Evaluation of CHROMagar Candida medium for the isolation of presumptive identification of species of Candida of clinical importance. Diagn. Microbiol. Infect. Dis. 24:201-204. - PubMed
- Bluestein, D., C. Rutledge, and L. Lumsden. 1991. Predicting the occurrence of antibiotic-induced candidal vaginitis (AICV). Fam. Pract. Res. J. 11:319-326. - PubMed
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous